OMIC - Singular Genomics Systems Inc
IEX Last Trade
7
-0.090 -1.286%
Share volume: 1,021
Last Updated: Fri 30 Aug 2024 09:00:28 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$7.09
-0.09
-1.27%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-07 | 2023-03-02 | 2023-05-09 | 2023-08-09 | 2023-11-14 | 2024-03-18 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 366.409 M | 345.475 M | 327.975 M | 305.466 M | 283.978 M | 284.518 M | 265.467 M | 239.101 M | |
| Current Assets | 305.950 M | 286.114 M | 268.432 M | 246.471 M | 225.693 M | 210.795 M | 192.228 M | 166.475 M | |
| Inventories | 12.216 M | 16.700 M | 18.221 M | 17.160 M | 14.354 M | 13.420 M | 13.572 M | 13.081 M | |
| Other Current Assets | 6.243 M | 5.574 M | 4.722 M | 3.224 M | 4.624 M | 6.259 M | 4.150 M | 2.519 M | |
| Short Term Investments | 6.243 M | 5.574 M | 4.722 M | 3.224 M | 4.624 M | 6.259 M | 4.150 M | 2.519 M | |
| Total Receivables | 0.000 | 0.000 | 913.000 K | 14.000 K | 32.000 K | 399.000 K | 565.000 K | 137.000 K | |
| Current Cash | 287.491 M | 263.840 M | 244.576 M | 226.073 M | 206.683 M | 190.717 M | 173.941 M | 150.738 M | |
| Total Non-current Assets | 60.459 M | 59.361 M | 59.543 M | 58.995 M | 58.285 M | 73.723 M | 73.239 M | 72.626 M | |
| Property Plant Equipment | 9.303 M | 9.589 M | 10.784 M | 11.259 M | 11.487 M | 13.426 M | 13.692 M | 13.854 M | |
| Other Assets | 49.422 M | 48.061 M | 47.048 M | 46.025 M | 45.087 M | 58.586 M | 58.947 M | 58.172 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 366.409 M | 345.475 M | 327.975 M | 305.466 M | 283.978 M | 284.518 M | 265.467 M | 239.101 M | |
| Total liabilities | 68.848 M | 68.550 M | 67.654 M | 65.141 M | 65.590 M | 85.491 M | 86.461 M | 82.403 M | |
| Total current liabilities | 13.312 M | 14.178 M | 14.118 M | 12.490 M | 13.950 M | 15.453 M | 18.287 M | 16.079 M | |
| Accounts Payable | 4.017 M | 2.975 M | 3.099 M | 1.977 M | 1.974 M | 2.432 M | 2.587 M | 2.012 M | |
| Other liabilities | 1.155 M | 1.023 M | 1.015 M | 998.000 K | 854.000 K | 739.000 K | 650.000 K | 605.000 K | |
| Current long term debt | 5.239 M | 5.703 M | 6.323 M | 6.952 M | 7.607 M | 7.706 M | 7.764 M | 7.822 M | |
| Long term debt | 54.381 M | 53.349 M | 52.521 M | 51.653 M | 50.786 M | 69.299 M | 67.524 M | 65.719 M | |
| Other liabilities | 1.155 M | 1.023 M | 1.015 M | 998.000 K | 854.000 K | 739.000 K | 650.000 K | 605.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 297.561 M | 276.925 M | 260.321 M | 240.325 M | 218.388 M | 199.027 M | 179.006 M | 156.698 M | |
| Common stock | 70.779 M | 71.216 M | 71.586 M | 71.926 M | 72.510 M | 73.179 M | 73.570 M | 73.926 M | |
| Retained earnings | -197.884 M | -221.674 M | -242.775 M | -266.408 M | -291.986 M | -314.346 M | -337.595 M | -362.619 M |